Centessa Pharmaceuticals PLC ADR Net Asset Quality Index

Latest as of March 2026: 75.9%

Centessa Pharmaceuticals PLC ADR net asset quality index. Centessa Pharmaceuticals PLC ADR (CNTA) has a Net Asset Quality Index of 75.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $641.76 Million minus total liabilities of $154.41 Million yields net assets of $487.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore Centessa Pharmaceuticals PLC ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Quality Index

75.9%
Equity / Total Assets

Net Assets

$487.35 Million
USD

Total Assets

$641.76 Million
USD

Total Liabilities

$154.41 Million
USD

Net Asset Quality Index of Centessa Pharmaceuticals PLC ADR (2019–2025)

Net asset quality index of Centessa Pharmaceuticals PLC ADR from 2019 to 2025. This chart shows how Centessa Pharmaceuticals PLC ADR's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 75.9%, representing net assets of $487.35 Million against total assets of $641.76 Million USD. See Centessa Pharmaceuticals PLC ADR shareholders equity for net asset value and shareholders' equity analysis.

Centessa Pharmaceuticals PLC ADR Net Asset Quality Index by Year (2019–2025)

Centessa Pharmaceuticals PLC ADR net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Centessa Pharmaceuticals PLC ADR from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CNTA company net worth.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 76.6% $526.86 Million $687.50 Million $160.63 Million ▲ +7.0 pp
2024 69.6% $401.55 Million $576.80 Million $175.25 Million ▲ +4.0 pp
2023 65.6% $236.24 Million $360.25 Million $124.00 Million ▼ -10.1 pp
2022 75.7% $336.17 Million $444.31 Million $108.14 Million ▼ -2.4 pp
2021 78.1% $491.55 Million $629.63 Million $138.08 Million ▲ +51.6 pp
2020 26.4% $3.10 Million $11.72 Million $8.62 Million ▼ -42.8 pp
2019 69.3% $13.66 Million $19.73 Million $6.07 Million —
pp = percentage points